MBX Biosciences, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +180.4% | +55.4% | +1.6% | |
| – | – | – | – | |
| – | +33.4% | +101.2% | +37.9% | |
| – | +80.0% | +59.1% | +75.3% | |
| – | +40.3% | +93.1% | +43.8% | |
| – | – | – | – | |
| – | -100.0% | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.